68 results
10QSB
2007 Q2
EX-10.1
LFVN
Lifevantage Corporation
12 Feb 07
Quarterly report (small business)
12:00am
reasonably be expected to harm the reputation, business, prospects or operations of Lifevantage or any of its respective directors or executive … of Lifevantage or other outside individuals or otherwise engage in any act that is intended or may reasonably be expected to harm the reputation, business
10QSB
2007 Q3
EX-10.19
LFVN
Lifevantage Corporation
14 May 07
Quarterly report (small business)
12:00am
agrees not to make any oral or written statements or otherwise engage in any act that is intended or may reasonably be expected to harm the reputation … or otherwise engage in any act that is intended or may reasonably be expected to harm the reputation, business or prospects of Executive.
14.Public Statements
8-K
EX-10.1
zbwuehz062zottawctcc
10 May 11
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
2fgvyxd
19 Dec 11
Lifevantage Provides Corporate Update
12:00am
8-K
EX-10.1
1cvrno25
3 Oct 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
1qxxjn
4 Jan 06
Lifeline Therapeutics, Inc. Names Gerald J. Houston Chief Financial Officer
12:00am
8-K
EX-10.1
p7p29
29 Nov 05
Lifeline Therapeutics Announces Appointment of Stephen K. Onody as Chief Executive Officer
12:00am
8-K
EX-10.1
ibznx1bod46v3
15 Feb 24
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.2
wug7c
25 Oct 21
LifeVantage Appoints Carl Aure as Chief Financial Officer
5:07pm